CCMH
ARRY

Cornerstone Capital Management Holdings’s Array Biopharma Inc ARRY Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.01M Sell
79,400
-8,000
-9% -$91K 0.01% 899
2017
Q3 		$1.07M Sell
87,400
-1,900
-2% -$17.6K 0.01% 913
2017
Q2 		$747K Buy
89,300
+7,745
+9% +$63.3K 0.01% 970
2017
Q1 		$728K Buy
81,555
+39,955
+96% +$425K 0.01% 989
2016
Q4 		$364K Sell
41,600
-126,700
-75% -$932K ﹤0.01% 1131
2016
Q3 		$1.14M Buy
168,300
+28,500
+20% +$110K 0.01% 919
2016
Q2 		$498K Sell
139,800
-206,600
-60% -$673K ﹤0.01% 1036
2016
Q1 		$1.02M Buy
346,400
+117,522
+51% +$352K 0.01% 907
2015
Q4 		$965K Buy
228,878
+226,277
+8,700% +$1.03M 0.01% 900
2015
Q3 		$12K Sell
2,601
-5,299
-67% -$31.4K ﹤0.01% 1470
2015
Q2 		$57K Buy
7,900
+5,900
+295% +$43.5K ﹤0.01% 1349
2015
Q1 		$15K Buy
+2,000
New +$14.2K ﹤0.01% 1350
2014
Q3 		– Sell
-68,800
Closed -$313K – 1382
2014
Q2 		$313K Buy
68,800
+22,300
+48% +$92.2K ﹤0.01% 1057
2014
Q1 		$219K Buy
46,500
+8,168
+21% +$41.1K ﹤0.01% 1103
2013
Q4 		$192K Buy
+38,332
New +$209K ﹤0.01% 1050
2013
Q3 		– Sell
-155,948
Closed -$709K – 1378
2013
Q2 		$709K Buy
+155,948
New +$839K 0.01% 870

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Cornerstone Capital Management Holdings's ARRY Position: Q4 2017 in Review

Cornerstone Capital Management Holdings reduced its Array Biopharma Inc (ARRY) stake by 9.2% in Q4 2017, selling an estimated $91K and leaving 79,400 shares worth $1.01M. The position accounts for 0.01% of the portfolio, ranked #899.

Cornerstone Capital Management Holdings first reported a position in ARRY in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.14M in Q3 2016. 191 funds tracked by Wall St. Rank hold ARRY as of Q4 2017.

  • Cornerstone Capital Management Holdings held 79,400 shares of Array Biopharma Inc worth $1.01M as of Q4 2017.
  • Cornerstone Capital Management Holdings sold 8,000 Array Biopharma Inc shares in Q4 2017, an estimated $91K.
  • Array Biopharma Inc made up 0.01% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #899 holding.
  • Cornerstone Capital Management Holdings first reported a position in Array Biopharma Inc in Q2 2013 and has held it in 16 quarters since.
  • Cornerstone Capital Management Holdings's Array Biopharma Inc position peaked at $1.14M in Q3 2016.
  • 191 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.